Key facts
- It has raised $12.5M across 1 recorded rounds; the latest was Accelerator/Incubator in Feb 2025.
- Notable investors include Springboard Enterprises, Lily Garfield, Merida Capital Holdings, Reed Oppenheimer.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Vella Bioscience
Funding rounds
1 roundsAbout Vella Bioscience
Manufacturer of sex care products intended to support female sexual pleasure and well-being. The company creates clinically validated, patented products that address the unmet needs specific to women's bodies and their sexual fulfillment, enabling women to increase their arousal and ease of orgasm, regardless of hormonal status.
- Industry
- Personal Products
- Sector
- Consumer Products and Services (B2C)
- HQ
- Tulsa, OK, United States
- Founded
- 2020
- Employees
- 10
- Website
- vellabio.com/
- Ownership
- Privately Held (backing)
Vella Bioscience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vella Bioscience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vella Bioscience in its N-PORT filings yet. We sweep new filings monthly.